Brazil
Tuberculosis profile
| High TB burden | High HIV burden |
Population  2012 199 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 4.9 (4.6–5.2) 2.5 (2.3–2.6)
Mortality (HIV+TB only) 2.5 (2.2–3) 1.3 (1.1–1.5)
Prevalence  (includes HIV+TB) 120 (51–210) 59 (25–107)
Incidence  (includes HIV+TB) 92 (76–110) 46 (38–55)
Incidence (HIV+TB only) 16 (13–19) 8 (6.6–9.5)
Case detection, all forms (%) 82 (69–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 40 152 (56) Relapse 3 867 (34)
Smear-negative 12 178 (17) Treatment after failure 296 (3)
Smear-unknown / not done 8 592 (12) Treatment after default 3 204 (28)
Extrapulmonary 10 297 (14) Other 4 133 (36)
Other 11 (<1)      
Total new 71 230   Total retreatment 11 500  
           
Other (history unknown) 25        
Total new and relapse 75 097   Total cases notified 82 755  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.3 1.8 1.5
Age < 15 580 1 266 542
Laboratories 2012
Smear (per 100 000 population) 2.0
Culture (per 5 million population) 5.5
Drug susceptibility testing (per 5 million population) 0.9
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 76   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 70  
Retreatment 49  
TB/HIV 2012 Number (%)
TB patients with known HIV status 45 733 (55)
HIV-positive TB patients 9 049 (20)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 0 (0)
HIV-positive TB patients on antiretroviral therapy (ART) 9 049 (100)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.4 (1–1.8) 7.5 (5.7–9.9)
MDR-TB cases among notified pulmonary
TB cases
850 (620–1 100) 860 (660–1 100)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 700 (2%) 198 (2%) 900
Laboratory-confirmed MDR-TB cases 562 122 684
Patients started on MDR-TB treatment     713
Financing TB control 2013
National TB programme budget (US$ millions) 87
% Funded domestically 84%
% Funded internationally 2%
% Unfunded 14%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-17 Data: www.who.int/tb/data